-
2
-
-
0001509014
-
Paralysisagitans. I. Pathologischesanatonie
-
Lewandowsky M, ed. Berlin, Germany: Springer
-
Lewy F. Paralysisagitans. I. Pathologischesanatonie. In: Lewandowsky M, ed. Handbuch der Neurologie. Berlin, Germany: Springer; 1912:920-933.
-
(1912)
Handbuch der Neurologie
, pp. 920-933
-
-
Lewy, F.1
-
3
-
-
0030744876
-
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
-
Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047.
-
(1997)
Science
, vol.276
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
Lavedan, C.2
Leroy, E.3
-
4
-
-
0031990490
-
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
-
Kruger R, Kuhn W, Muller T, et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998;18:106-108.
-
(1998)
Nat Genet
, vol.18
, pp. 106-108
-
-
Kruger, R.1
Kuhn, W.2
Muller, T.3
-
5
-
-
10744230149
-
The new mutation. E46K, of alpha-synuclein causes Parkinson and Lewy body dementia
-
Zarranz JJ, Alegre J, Gomez-Esteban JC, et al. The new mutation. E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55:164-173.
-
(2004)
Ann Neurol
, vol.55
, pp. 164-173
-
-
Zarranz, J.J.1
Alegre, J.2
Gomez-Esteban, J.C.3
-
6
-
-
0242300619
-
Alpha-synuclein locus triplication causes Parkinson's disease
-
Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science. 2003;302:841.
-
(2003)
Science
, vol.302
, pp. 841
-
-
Singleton, A.B.1
Farrer, M.2
Johnson, J.3
-
7
-
-
10744227740
-
Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications
-
Farrer M, Kachergus J, Fomo L, et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol. 2004;55:174-179.
-
(2004)
Ann Neurol
, vol.55
, pp. 174-179
-
-
Farrer, M.1
Kachergus, J.2
Fomo, L.3
-
8
-
-
4644290985
-
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease
-
Chartier-Harlin MC, Kachergus J, Roumier C, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet. 2004;364:1167-1169.
-
(2004)
Lancet
, vol.364
, pp. 1167-1169
-
-
Chartier-Harlin, M.C.1
Kachergus, J.2
Roumier, C.3
-
9
-
-
0032568534
-
Alha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies
-
Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc Natl Acad Sci U S A. 1998;95:6469-6473.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 6469-6473
-
-
Spillantini, M.G.1
Crowther, R.A.2
Jakes, R.3
Hasegawa, M.4
Goedert, M.5
-
10
-
-
0036777211
-
Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses
-
Trojanowski JQ, Lee VM. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses. Neurotoxicology. 2002;23:457-460.
-
(2002)
Neurotoxicology
, vol.23
, pp. 457-460
-
-
Trojanowski, J.Q.1
Lee, V.M.2
-
11
-
-
0042767676
-
Parkinson's disease: Piecing together a genetic jigsaw
-
Dekker MC, Bonifati V, van Duijn CM. Parkinson's disease: piecing together a genetic jigsaw. Brain. 2003;126(pt 8):1722-1733.
-
(2003)
Brain
, vol.126
, Issue.PART 8
, pp. 1722-1733
-
-
Dekker, M.C.1
Bonifati, V.2
Van Duijn, C.M.3
-
12
-
-
0038413759
-
Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function
-
Snyder H, Mensah K, Theisler C, Lee J, Matouschek A, Wolozin B. Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J Biol Chem. 2003;278:11753-11759.
-
(2003)
J Biol Chem
, vol.278
, pp. 11753-11759
-
-
Snyder, H.1
Mensah, K.2
Theisler, C.3
Lee, J.4
Matouschek, A.5
Wolozin, B.6
-
13
-
-
0035894855
-
Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death
-
Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci. 2001;21:9549-9560.
-
(2001)
J Neurosci
, vol.21
, pp. 9549-9560
-
-
Stefanis, L.1
Larsen, K.E.2
Rideout, H.J.3
Sulzer, D.4
Greene, L.A.5
-
14
-
-
0035870881
-
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases seasitivity to mitochondria-dependent apoptosis
-
Tanaka Y, Engelender S, Igarashi S, et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases seasitivity to mitochondria-dependent apoptosis. Hum Mol Genet. 2001;10:919-926.
-
(2001)
Hum Mol Genet
, vol.10
, pp. 919-926
-
-
Tanaka, Y.1
Engelender, S.2
Igarashi, S.3
-
15
-
-
0035409575
-
Alpha-synuclein and neurodegenerative diseases
-
Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci. 2001;2:492-501.
-
(2001)
Nat Rev Neurosci
, vol.2
, pp. 492-501
-
-
Goedert, M.1
-
16
-
-
0033215063
-
Synucleins in synaptic plasticity and neurodegenerative disorders
-
Clayton DF, George JM. Synucleins in synaptic plasticity and neurodegenerative disorders. J Neurosci Res. 1999;58:120-129.
-
(1999)
J Neurosci Res
, vol.58
, pp. 120-129
-
-
Clayton, D.F.1
George, J.M.2
-
17
-
-
0032102455
-
The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease
-
Clayton DF, George JM. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 1998;21:249-254.
-
(1998)
Trends Neurosci
, vol.21
, pp. 249-254
-
-
Clayton, D.F.1
George, J.M.2
-
18
-
-
0141891097
-
The association of alpha-synuclein with membranes affects bilayer structure, stability and fibril formation
-
Zhu M, Li J, Fink AL. The association of alpha-synuclein with membranes affects bilayer structure, stability and fibril formation. J Biol Chem. 2003;278:40186-40197.
-
(2003)
J Biol Chem
, vol.278
, pp. 40186-40197
-
-
Zhu, M.1
Li, J.2
Fink, A.L.3
-
19
-
-
0034193399
-
Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons
-
Murphy DD, Rueter SM, Trojanowski JQ, Lee VM. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J Neurosci. 2000;20:3214-3220.
-
(2000)
J Neurosci
, vol.20
, pp. 3214-3220
-
-
Murphy, D.D.1
Rueter, S.M.2
Trojanowski, J.Q.3
Lee, V.M.4
-
20
-
-
0034077041
-
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
-
Abeliovich A, Schmitz Y, Farinas I, et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron. 2000;25:239-252.
-
(2000)
Neuron
, vol.25
, pp. 239-252
-
-
Abeliovich, A.1
Schmitz, Y.2
Farinas, I.3
-
21
-
-
0037109727
-
Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein
-
Cabin DE, Shimazu K, Murphy D, et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J Neurosci. 2002;22:8797-8807.
-
(2002)
J Neurosci
, vol.22
, pp. 8797-8807
-
-
Cabin, D.E.1
Shimazu, K.2
Murphy, D.3
-
22
-
-
0037456578
-
The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease
-
Sharon R, Bar-Joseph I, Frosch MP, Walsh DM, Hamilton JA, Selkoe DJ. The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron. 2003;37:583-595.
-
(2003)
Neuron
, vol.37
, pp. 583-595
-
-
Sharon, R.1
Bar-Joseph, I.2
Frosch, M.P.3
Walsh, D.M.4
Hamilton, J.A.5
Selkoe, D.J.6
-
23
-
-
0037046163
-
Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism
-
Volles MJ, Lansbury PT Jr. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry. 2002;41:4595-4602.
-
(2002)
Biochemistry
, vol.41
, pp. 4595-4602
-
-
Volles, M.J.1
Lansbury Jr., P.T.2
-
24
-
-
0036415838
-
Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils
-
Lashuel HA, Petre BM, Wall J, et al. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol. 2002;322:1089-1102.
-
(2002)
J Mol Biol
, vol.322
, pp. 1089-1102
-
-
Lashuel, H.A.1
Petre, B.M.2
Wall, J.3
-
25
-
-
0034528027
-
Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants
-
Conway KA, Lee SJ, Rochet JC, et al. Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann N Y Acad Sci. 2000;920:42-45.
-
(2000)
Ann N Y Acad Sci
, vol.920
, pp. 42-45
-
-
Conway, K.A.1
Lee, S.J.2
Rochet, J.C.3
-
26
-
-
0031787871
-
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease
-
Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med. 1998;4:1318-1320.
-
(1998)
Nat Med
, vol.4
, pp. 1318-1320
-
-
Conway, K.A.1
Harper, J.D.2
Lansbury, P.T.3
-
27
-
-
0032563519
-
Parkinson disease. Alpha-synuclein is the first molecular help
-
Jensen PH, Gliemann J. Parkinson disease. Alpha-synuclein is the first molecular help [Danish]. Ugeskr Laeger. 1998;160:5054-5055.
-
(1998)
Ugeskr Laeger
, vol.160
, pp. 5054-5055
-
-
Jensen, P.H.1
Gliemann, J.2
-
28
-
-
0036307753
-
Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein
-
Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. J Mol Biol. 2002;315:799-807.
-
(2002)
J Mol Biol
, vol.315
, pp. 799-807
-
-
Jo, E.1
Fuller, N.2
Rand, R.P.3
St. George-Hyslop, P.4
Fraser, P.E.5
-
29
-
-
0034602442
-
Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions
-
Giasson BI, Duda JE, Murray IV, et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000;290:985-989.
-
(2000)
Science
, vol.290
, pp. 985-989
-
-
Giasson, B.I.1
Duda, J.E.2
Murray, I.V.3
-
30
-
-
0034660568
-
Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide
-
Paik SR, Shin HJ, Lee JH. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide. Arch Biochem Biophys. 2000;378:269-277.
-
(2000)
Arch Biochem Biophys
, vol.378
, pp. 269-277
-
-
Paik, S.R.1
Shin, H.J.2
Lee, J.H.3
-
31
-
-
0035887860
-
Induction of alpha-synuclein aggregation by intracellular nitrative insult
-
Paxinou E, Chen Q, Weisse M, et al. Induction of alpha-synuclein aggregation by intracellular nitrative insult. J Neurosci. 2001;21:8053-8061.
-
(2001)
J Neurosci
, vol.21
, pp. 8053-8061
-
-
Paxinou, E.1
Chen, Q.2
Weisse, M.3
-
32
-
-
0037378026
-
Oxidative stress in Parkinson's disease
-
Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003;53 (suppl 3):S26-36.
-
(2003)
Ann Neurol
, vol.53
, Issue.SUPPL. 3
-
-
Jenner, P.1
-
33
-
-
0024585155
-
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
-
Dexter DT, Carter CJ, Wells FR, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem. 1989;52:381-389.
-
(1989)
J Neurochem
, vol.52
, pp. 381-389
-
-
Dexter, D.T.1
Carter, C.J.2
Wells, F.R.3
-
34
-
-
0027952849
-
Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study
-
Dexter DT, Holley AE, Flitter WD, et al. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord. 1994;9:92-97.
-
(1994)
Mov Disord
, vol.9
, pp. 92-97
-
-
Dexter, D.T.1
Holley, A.E.2
Flitter, W.D.3
-
35
-
-
0028075410
-
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
-
Sian J, Dexter DT, Lees AJ, et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol. 1994;36:348-355.
-
(1994)
Ann Neurol
, vol.36
, pp. 348-355
-
-
Sian, J.1
Dexter, D.T.2
Lees, A.J.3
-
36
-
-
0025640845
-
Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease
-
Schapira AH, Mann VM, Cooper JM, et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem. 1990;55:2142-2145.
-
(1990)
J Neurochem
, vol.55
, pp. 2142-2145
-
-
Schapira, A.H.1
Mann, V.M.2
Cooper, J.M.3
-
37
-
-
0022553605
-
Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients
-
Perry TL, Yong VW. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett. 1986;67:269-274.
-
(1986)
Neurosci Lett
, vol.67
, pp. 269-274
-
-
Perry, T.L.1
Yong, V.W.2
-
38
-
-
0024330311
-
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
-
Mizuno Y, Ohta S, Tanaka M, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun. 1989;163:1450-1455.
-
(1989)
Biochem Biophys Res Commun
, vol.163
, pp. 1450-1455
-
-
Mizuno, Y.1
Ohta, S.2
Tanaka, M.3
-
39
-
-
0025047351
-
Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect
-
Lestienne P, Nelson J, Riederer P, Jellinger K, Reichmann H. Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. J Neurochem. 1990;55:1810-1812.
-
(1990)
J Neurochem
, vol.55
, pp. 1810-1812
-
-
Lestienne, P.1
Nelson, J.2
Riederer, P.3
Jellinger, K.4
Reichmann, H.5
-
40
-
-
0036014117
-
Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase
-
Elkon H, Don J, Melamed E, Ziv I, Shirvan A, Offen D. Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase. J Mol Neurosci. 2002;18:229-238.
-
(2002)
J Mol Neurosci
, vol.18
, pp. 229-238
-
-
Elkon, H.1
Don, J.2
Melamed, E.3
Ziv, I.4
Shirvan, A.5
Offen, D.6
-
41
-
-
0033773403
-
Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein
-
Ko L, Mehta ND, Farrer M, et al. Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein. J Neurochem. 2000;75:2546-2554.
-
(2000)
J Neurochem
, vol.75
, pp. 2546-2554
-
-
Ko, L.1
Mehta, N.D.2
Farrer, M.3
-
42
-
-
0034008852
-
Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation
-
Kanda S, Bishop JF, Eglitis MA, Yang Y, Mouradian MM. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. Neuroscience. 2000;97:279-284.
-
(2000)
Neuroscience
, vol.97
, pp. 279-284
-
-
Kanda, S.1
Bishop, J.F.2
Eglitis, M.A.3
Yang, Y.4
Mouradian, M.M.5
-
43
-
-
0035449454
-
Glial cell death induced by overexpression of alpha-synuclein
-
Stefanova N, Klimaschewski L, Poewe W, Wenning GK, Reindl M. Glial cell death induced by overexpression of alpha-synuclein. J Neurosci Res. 2001;65:432-438.
-
(2001)
J Neurosci Res
, vol.65
, pp. 432-438
-
-
Stefanova, N.1
Klimaschewski, L.2
Poewe, W.3
Wenning, G.K.4
Reindl, M.5
-
44
-
-
0033890821
-
Alpha-synuclein promotes mitochondrial deficit and oxidative stress
-
Hsu LJ, Sagara Y, Arroyo A, et al. alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol. 2000;157:401-410.
-
(2000)
Am J Pathol
, vol.157
, pp. 401-410
-
-
Hsu, L.J.1
Sagara, Y.2
Arroyo, A.3
-
45
-
-
0035873812
-
Alpha-synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro
-
Turnbull S, Tabner BJ, El-Agnaf OM, Moore S, Davies Y, Allsop D. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. Free Radic Biol Med. 2001;30:1163-1170.
-
(2001)
Free Radic Biol Med
, vol.30
, pp. 1163-1170
-
-
Turnbull, S.1
Tabner, B.J.2
El-Agnaf, O.M.3
Moore, S.4
Davies, Y.5
Allsop, D.6
-
46
-
-
0035109909
-
Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult
-
Lee M, Hyun D, Halliwell B, Jenner P. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J Neurochem. 2001;76:998-1009.
-
(2001)
J Neurochem
, vol.76
, pp. 998-1009
-
-
Lee, M.1
Hyun, D.2
Halliwell, B.3
Jenner, P.4
-
47
-
-
0036278335
-
Dopamine-dependent neurotoxicity of alpha-synuclein: A mechanism for selective neurodegeneration in Parkinson disease
-
Xu J, Kao SY, Lee FJ, Song W, Jin LW, Yankner BA. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med. 2002;8:600-606.
-
(2002)
Nat Med
, vol.8
, pp. 600-606
-
-
Xu, J.1
Kao, S.Y.2
Lee, F.J.3
Song, W.4
Jin, L.W.5
Yankner, B.A.6
-
48
-
-
0036468957
-
Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture
-
Zhou W, Schaack J, Zawada WM, Freed CR. Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture. Brain Res. 2002;926:42-50.
-
(2002)
Brain Res
, vol.926
, pp. 42-50
-
-
Zhou, W.1
Schaack, J.2
Zawada, W.M.3
Freed, C.R.4
-
49
-
-
0035066885
-
Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
-
Lee FJ, Liu F, Pristupa ZB, Niznik HB. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. Faseb J. 2001;15:916-926.
-
(2001)
Faseb J
, vol.15
, pp. 916-926
-
-
Lee, F.J.1
Liu, F.2
Pristupa, Z.B.3
Niznik, H.B.4
-
50
-
-
0037064078
-
Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line
-
Lotharius J, Barg S, Wiekop P, Lundberg C, Raymon HK, Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem. 2002;277:38884-38894.
-
(2002)
J Biol Chem
, vol.277
, pp. 38884-38894
-
-
Lotharius, J.1
Barg, S.2
Wiekop, P.3
Lundberg, C.4
Raymon, H.K.5
Brundin, P.6
-
51
-
-
0037092442
-
A role for alpha-synuclein in the regulation of dopamine biosynthesis
-
Perez RG, Waymire JC, Lin E, Liu JJ, Guo F, Zigmond MJ. A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci. 2002;22:3090-3099.
-
(2002)
J Neurosci
, vol.22
, pp. 3090-3099
-
-
Perez, R.G.1
Waymire, J.C.2
Lin, E.3
Liu, J.J.4
Guo, F.5
Zigmond, M.J.6
-
52
-
-
0035567927
-
6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: Implications for the pathogenesis of Parkinson's disease
-
Elkon H, Melamed E, Offen D. 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease. Cell Mol Neurobiol. 2001;21:771-781.
-
(2001)
Cell Mol Neurobiol
, vol.21
, pp. 771-781
-
-
Elkon, H.1
Melamed, E.2
Offen, D.3
-
53
-
-
0034993599
-
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease
-
Blum D, Torch S, Lambeng N, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol. 2001;65:135-172.
-
(2001)
Prog Neurobiol
, vol.65
, pp. 135-172
-
-
Blum, D.1
Torch, S.2
Lambeng, N.3
-
54
-
-
0023503459
-
The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is near the Q-binding site of NADH dehydrogenase
-
Ramsay RR, Kowal AT, Johnson MK, Salach JI, Singer TP. The inhibition site of MPP+, the neurotoxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine is near the Q-binding site of NADH dehydrogenase. Arch Biochem Biophys. 1987;259:645-649.
-
(1987)
Arch Biochem Biophys
, vol.259
, pp. 645-649
-
-
Ramsay, R.R.1
Kowal, A.T.2
Johnson, M.K.3
Salach, J.I.4
Singer, T.P.5
-
55
-
-
0025116342
-
Mechanism of the neurotoxicity of MPTP An update
-
Singer TP, Ramsay RR. Mechanism of the neurotoxicity of MPTP An update. FEBS Lett. 1990;274:1-8.
-
(1990)
FEBS Lett
, vol.274
, pp. 1-8
-
-
Singer, T.P.1
Ramsay, R.R.2
-
56
-
-
0034624017
-
The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity
-
Lotharius J, O'Malley KL. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem. 2000;275:38581-38588.
-
(2000)
J Biol Chem
, vol.275
, pp. 38581-38588
-
-
Lotharius, J.1
O'Malley, K.L.2
-
57
-
-
0141741347
-
Parkinson's disease: Mechanisms and models
-
Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron. 2003;39:889-909.
-
(2003)
Neuron
, vol.39
, pp. 889-909
-
-
Dauer, W.1
Przedborski, S.2
-
58
-
-
0038249170
-
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
-
May
-
Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med. May 2003;9:589-595.
-
(2003)
Nat Med
, vol.9
, pp. 589-595
-
-
Gill, S.S.1
Patel, N.K.2
Hotton, G.R.3
-
59
-
-
0034659835
-
Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system
-
Kirik D, Rosenblad C, Bjorklund A, Mandel RJ. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci. 2000;20:4686-4700.
-
(2000)
J Neurosci
, vol.20
, pp. 4686-4700
-
-
Kirik, D.1
Rosenblad, C.2
Bjorklund, A.3
Mandel, R.J.4
-
60
-
-
0028834063
-
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
-
Tomac A, Lindqvist E, Lin LF, et al. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 1995;373:335-339.
-
(1995)
Nature
, vol.373
, pp. 335-339
-
-
Tomac, A.1
Lindqvist, E.2
Lin, L.F.3
-
61
-
-
0034721690
-
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
-
Kordower JH, Emborg ME, Bloch J, et al. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science. 2000;290:767-773.
-
(2000)
Science
, vol.290
, pp. 767-773
-
-
Kordower, J.H.1
Emborg, M.E.2
Bloch, J.3
-
62
-
-
0036787532
-
Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys
-
Grondin R, Zhang Z, Yi A, et al. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain. 2002;125(pt 10):2191-2201.
-
(2002)
Brain
, vol.125
, Issue.PART 10
, pp. 2191-2201
-
-
Grondin, R.1
Zhang, Z.2
Yi, A.3
-
63
-
-
0033681149
-
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
-
Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000;3:1301-1306.
-
(2000)
Nat Neurosci
, vol.3
, pp. 1301-1306
-
-
Betarbet, R.1
Sherer, T.B.2
MacKenzie, G.3
Garcia-Osuna, M.4
Panov, A.V.5
Greenamyre, J.T.6
-
64
-
-
0037314540
-
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
-
Hoglinger GU, Feger J, Prigent A, et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem. 2003;84:491-502.
-
(2003)
J Neurochem
, vol.84
, pp. 491-502
-
-
Hoglinger, G.U.1
Feger, J.2
Prigent, A.3
-
65
-
-
3042794162
-
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
-
McNaught KS, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol. 2004;56:149-162.
-
(2004)
Ann Neurol
, vol.56
, pp. 149-162
-
-
McNaught, K.S.1
Perl, D.P.2
Brownell, A.L.3
Olanow, C.W.4
-
66
-
-
0034681471
-
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
-
Masliah E, Rockenstein E, Veinbergs I, et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science. 2000;287:1265-1269.
-
(2000)
Science
, vol.287
, pp. 1265-1269
-
-
Masliah, E.1
Rockenstein, E.2
Veinbergs, I.3
-
67
-
-
0035017068
-
Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice
-
Rathke-Hartlieb S, Kahle PJ, Neumann M, et al. Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice. J Neurochem. 2001;77:1181-1184.
-
(2001)
J Neurochem
, vol.77
, pp. 1181-1184
-
-
Rathke-Hartlieb, S.1
Kahle, P.J.2
Neumann, M.3
-
68
-
-
0034979314
-
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter
-
Matsuoka Y, Vila M, Lincoln S, et al. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis. 2001;8:535-539.
-
(2001)
Neurobiol Dis
, vol.8
, pp. 535-539
-
-
Matsuoka, Y.1
Vila, M.2
Lincoln, S.3
-
69
-
-
0036245056
-
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice
-
Richfield EK, Thirachelvam MJ, Cory-Slechta DA, et al. Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol. 2002;175:35-48.
-
(2002)
Exp Neurol
, vol.175
, pp. 35-48
-
-
Richfield, E.K.1
Thirachelvam, M.J.2
Cory-Slechta, D.A.3
-
70
-
-
0037118259
-
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein
-
Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron. 2002;34:521-533.
-
(2002)
Neuron
, vol.34
, pp. 521-533
-
-
Giasson, B.I.1
Duda, J.E.2
Quinn, S.M.3
Zhang, B.4
Trojanowski, J.Q.5
Lee, V.M.6
-
71
-
-
0037173006
-
Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 -β> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice
-
Lee MK, Stirling W, Xu Y, et al. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 -β> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc Natl Acad Sci U S A. 2002;99:8968-8973.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 8968-8973
-
-
Lee, M.K.1
Stirling, W.2
Xu, Y.3
-
72
-
-
0034663176
-
Neuropathology in mice expressing human alpha-synuclein
-
van der Putten H, Wiederhold KH, Probst A, et al. Neuropathology in mice expressing human alpha-synuclein. J Neurosci. 2000;20:6021-6029.
-
(2000)
J Neurosci
, vol.20
, pp. 6021-6029
-
-
Van Der Putten, H.1
Wiederhold, K.H.2
Probst, A.3
-
73
-
-
0034280435
-
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain
-
Kahle PJ, Neumann M, Ozmen L, et al. Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci. 2000;20:6365-6373.
-
(2000)
J Neurosci
, vol.20
, pp. 6365-6373
-
-
Kahle, P.J.1
Neumann, M.2
Ozmen, L.3
-
74
-
-
0035191413
-
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model
-
Kahle PJ, Neumann M, Ozmen L, et al. Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model. Am J Pathol. 2001;159:2215-2225.
-
(2001)
Am J Pathol
, vol.159
, pp. 2215-2225
-
-
Kahle, P.J.1
Neumann, M.2
Ozmen, L.3
-
75
-
-
0034704752
-
A Drosophila model of Parkinson's disease
-
Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature. 2000;404:394-398.
-
(2000)
Nature
, vol.404
, pp. 394-398
-
-
Feany, M.B.1
Bender, W.W.2
-
76
-
-
0034704813
-
Parkinson's pathology in a fly
-
Haass C, Kahle PJ. Parkinson's pathology in a fly. Nature. 2000;404:341-343.
-
(2000)
Nature
, vol.404
, pp. 341-343
-
-
Haass, C.1
Kahle, P.J.2
-
77
-
-
0037971209
-
Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein
-
Lakso M, Vartiainen S, Moilanen AM, et al. Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem. 2003;86:165-172.
-
(2003)
J Neurochem
, vol.86
, pp. 165-172
-
-
Lakso, M.1
Vartiainen, S.2
Moilanen, A.M.3
-
78
-
-
0345269757
-
Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: A new primate model of Parkinson's disease
-
Kirik D, Annett LE, Burger C, Muzyczka N, Mandel RJ, Bjorklund A. Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease. Proc Natl Acad Sci U S A. 2003;100:2884-2889.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 2884-2889
-
-
Kirik, D.1
Annett, L.E.2
Burger, C.3
Muzyczka, N.4
Mandel, R.J.5
Bjorklund, A.6
-
79
-
-
0036550101
-
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system
-
Kirik D, Rosenblad C, Burger C, et al. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J Neurosci. 2002;22:2780-2791.
-
(2002)
J Neurosci
, vol.22
, pp. 2780-2791
-
-
Kirik, D.1
Rosenblad, C.2
Burger, C.3
-
80
-
-
0036679197
-
Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease
-
002
-
Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P. alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc Natl Acad Sci U S A. 002;99:10813-10818.
-
Proc Natl Acad Sci U S A
, vol.99
, pp. 10813-10818
-
-
Lo Bianco, C.1
Ridet, J.L.2
Schneider, B.L.3
Deglon, N.4
Aebischer, P.5
-
81
-
-
0041625923
-
Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein
-
Lauwers E, Debyser Z, Van Dorpe J, De Strooper B, Nuttin B, Baekelandt V. Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein. Brain Pathol. 2003;13:364-372.
-
(2003)
Brain Pathol
, vol.13
, pp. 364-372
-
-
Lauwers, E.1
Debyser, Z.2
Van Dorpe, J.3
De Strooper, B.4
Nuttin, B.5
Baekelandt, V.6
-
82
-
-
0026525713
-
Use of adeno-associated virus as a general transduction vector for mammalian cells
-
Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr Top Microbiol Immunol. 1992;158:97-129.
-
(1992)
Curr Top Microbiol Immunol
, vol.158
, pp. 97-129
-
-
Muzyczka, N.1
-
83
-
-
1542369977
-
From virus evolution to vector revolution: Use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy
-
Grimm D, Kay MA. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther. 2003;3:281-304.
-
(2003)
Curr Gene Ther
, vol.3
, pp. 281-304
-
-
Grimm, D.1
Kay, M.A.2
-
84
-
-
0031456051
-
Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats
-
Mandel RJ, Spratt SK, Snyder RO, Leff SE. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci U S A. 1997;94:14083-14088.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 14083-14088
-
-
Mandel, R.J.1
Spratt, S.K.2
Snyder, R.O.3
Leff, S.E.4
-
85
-
-
0032550793
-
Selective and rapid uptake of adeno-associated virus type 2 in brain
-
Bartlett JS, Samulski RJ, McCown TJ. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther. 1998;9:1181-1136.
-
(1998)
Hum Gene Ther
, vol.9
, pp. 1181-1136
-
-
Bartlett, J.S.1
Samulski, R.J.2
McCown, T.J.3
-
86
-
-
0031014887
-
Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters
-
Peel AL, Zolotukhin S, Schrimsher GW, Muzyczka N, Reier PJ. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters. Gene Ther. 1997;4:16-24.
-
(1997)
Gene Ther
, vol.4
, pp. 16-24
-
-
Peel, A.L.1
Zolotukhin, S.2
Schrimsher, G.W.3
Muzyczka, N.4
Reier, P.J.5
-
87
-
-
0033773237
-
Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor
-
Kirik D, Rosenblad C, Bjorklund A. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur J Neurosci. 2000;12:3871-3882.
-
(2000)
Eur J Neurosci
, vol.12
, pp. 3871-3882
-
-
Kirik, D.1
Rosenblad, C.2
Bjorklund, A.3
-
88
-
-
0032143368
-
Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat
-
Kirik D, Rosenblad C, Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol. 1998;152:259-277.
-
(1998)
Exp Neurol
, vol.152
, pp. 259-277
-
-
Kirik, D.1
Rosenblad, C.2
Bjorklund, A.3
-
89
-
-
0029047329
-
Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion
-
Sauer H, Rosenblad C, Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci U S A. 1995;92:8935-8939.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 8935-8939
-
-
Sauer, H.1
Rosenblad, C.2
Bjorklund, A.3
-
90
-
-
0036202813
-
Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra
-
Klein RL, King MA, Hamby ME, Meyer EM. Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum Gene Ther. 2002;13:605-612
-
(2002)
Hum Gene Ther
, vol.13
, pp. 605-612
-
-
Klein, R.L.1
King, M.A.2
Hamby, M.E.3
Meyer, E.M.4
-
91
-
-
0034745919
-
Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease
-
Schmidt N, Ferger B. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease. Synapse. 2001;40:47-54.
-
(2001)
Synapse
, vol.40
, pp. 47-54
-
-
Schmidt, N.1
Ferger, B.2
-
92
-
-
0035214256
-
Neurochemical findings in the MPTP model of Parkinson's disease
-
Schmidt N, Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J Neural Transm. 2001;108:1263-1282.
-
(2001)
J Neural Transm
, vol.108
, pp. 1263-1282
-
-
Schmidt, N.1
Ferger, B.2
-
93
-
-
0035960066
-
Mouse model of parkinsonism: A comparison between subacute MPTP and chronic MPTP/probenecid treatment
-
Petroske E, Meredith GE, Callen S, Totterdell S, Lau YS. Mouse model of parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment. Neuroscience. 2001;106:589-601.
-
(2001)
Neuroscience
, vol.106
, pp. 589-601
-
-
Petroske, E.1
Meredith, G.E.2
Callen, S.3
Totterdell, S.4
Lau, Y.S.5
-
94
-
-
0037126181
-
Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats
-
Alam M, Schmidt WJ. Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res. 2002;136:317-323.
-
(2002)
Behav Brain Res
, vol.136
, pp. 317-323
-
-
Alam, M.1
Schmidt, W.J.2
-
95
-
-
0033608811
-
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
-
Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 1999;823:1-10.
-
(1999)
Brain Res
, vol.823
, pp. 1-10
-
-
Brooks, A.I.1
Chadwick, C.A.2
Gelbard, H.A.3
Cory-Slechta, D.A.4
Federoff, H.J.5
-
96
-
-
0037127197
-
The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: Paraquat and alpha-synuclein
-
Manning-Bog AB, McCormack AL, Li J, Uversky VN, Fink AL, Di Monte DA. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein. J Biol Chem. 2002;277:1641-1644.
-
(2002)
J Biol Chem
, vol.277
, pp. 1641-1644
-
-
Manning-Bog, A.B.1
McCormack, A.L.2
Li, J.3
Uversky, V.N.4
Fink, A.L.5
Di Monte, D.A.6
-
97
-
-
0036075892
-
Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat
-
McCormack AL, Thiruchelvam M, Manning-Bog AB, et al. Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis. 2002;10:119-127.
-
(2002)
Neurobiol Dis
, vol.10
, pp. 119-127
-
-
McCormack, A.L.1
Thiruchelvam, M.2
Manning-Bog, A.B.3
-
98
-
-
0036580677
-
Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length
-
de Almeida LP, Ross CA, Zala D, Aebischer P, Deglon N. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J Neurosci. 2002;22:3473-3483.
-
(2002)
J Neurosci
, vol.22
, pp. 3473-3483
-
-
De Almeida, L.P.1
Ross, C.A.2
Zala, D.3
Aebischer, P.4
Deglon, N.5
-
99
-
-
0034007822
-
Pathoanatomy of Parkinson's disease
-
Braak H, Braak E. Pathoanatomy of Parkinson's disease. J Neurol 2000;247(suppl 2):II3-II10.
-
(2000)
J Neurol
, vol.247
, Issue.SUPPL. 2
-
-
Braak, H.1
Braak, E.2
|